RAS Subcellular Localization Inversely Regulates Thyroid Tumor Growth and Dissemination

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• RAS mutations are common in thyroid tumors but their link to aggressive phenotypes remains unclear.
• RAS-mutant thyroid tumors are often classified as undetermined, complicating clinical management and treatment decisions.

Purpose of the Study:

• To investigate the role of HRAS subcellular localization in thyroid tumor aggressiveness.
• To identify factors regulating HRAS function in thyroid cancer.
• To explore the potential of APT-1 as a prognostic biomarker for HRAS-mutant thyroid tumors.

Main Methods:

• Utilized a chick embryo spontaneous metastasis model to assess thyroid cell aggressiveness.
• Investigated the correlation between HRAS subcellular localization, tumor size, and metastasis.
• Analyzed the role of VEGF-B secretion in RAS-driven tumor growth and dissemination.
• Examined the function of acyl protein thioesterase APT-1 in regulating HRAS localization and thyroid tumor behavior.
• Validated APT-1 as a prognostic factor in clinical thyroid cancer samples.

Main Results:

• HRAS subcellular localization dictates the aggressiveness of HRAS-transformed thyroid cells, including their metastatic potential.
• Tumor aggressiveness inversely correlates with tumor size.
• RAS-mediated tumor growth and dissemination depend on VEGF-B secretion.
• APT-1 regulates HRAS sublocalization to specific plasma membrane microdomains, thereby controlling thyroid tumor growth versus dissemination.
• APT-1 levels are a prognostic factor in clinical thyroid cancer samples.

Conclusions:

• HRAS subcellular localization is a key determinant of thyroid tumor aggressiveness.
• APT-1 plays a critical role in regulating HRAS function and thyroid tumor behavior.
• APT-1 has potential as a biomarker for stratifying HRAS-mutant thyroid tumors based on aggressiveness, aiding in personalized treatment strategies.